Metastatic Non-Small Cell Lung Cancer Recruiting Phase 1 Trials for Cetuximab (DB00002)

Also known as: Metastatic untreated non small cell lung cancer / Non-Small Cell Lung Cancer Metastatic / Metastatic Non-small Cell Lung Cancer (NSCLC) / Metastatic Non-Small-Cell Lung Cancer / Lung cancer non-small cell stage IV / Non-small cell lung cancer stage IV

IndicationStatusPhase
DBCOND0043377 (Metastatic Non-Small Cell Lung Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02857270A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic CancerTreatment